ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 1155

$368K Total Retail Price of All Prescriptions

Rank: 143 out of 1155

360 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 6,981 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LOVASTATIN 432 360 1 13
METFORMIN HCL 331 231 2 7
LEVOTHYROXINE SODIUM 319 271 3 2
GABAPENTIN 295 226 4 15
OMEPRAZOLE 292 223 5 5
LISINOPRIL 236 201 6 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 226 202 7 26
CITALOPRAM HBR 221 216 8 19
FUROSEMIDE 220 184 9 8
ATORVASTATIN CALCIUM 212 193 10 12
METOPROLOL SUCCINATE 210 194 11 17
TRAMADOL HCL 183 122 12 32
SIMVASTATIN 152 146 13 3
ATENOLOL 146 128 14 10
BENAZEPRIL HCL 144 118 15 85
TAMSULOSIN HCL 124 117 16 27
OXYBUTYNIN CHLORIDE 115 82 17 71
METHADONE HCL 113 97 S2 18 50
BENAZEPRIL-HYDROCHLOROTHIAZIDE 110 110 19 190
ALLOPURINOL 107 91 20 29
MIRTAZAPINE 107 102 20 61
ISOSORBIDE MONONITRATE ER 105 105 22 87
WARFARIN SODIUM 101 76 23 11
SERTRALINE HCL 92 82 24 24
ROPINIROLE HCL 89 77 25 94
FLUTICASONE PROPIONATE 89 73 25 37
TIZANIDINE HCL 88 59 27 121
LANTUS 87 80 28 39
CARVEDILOL 86 86 29 28
VENLAFAXINE HCL 79 35 30 164
LOSARTAN POTASSIUM 78 75 31 18
AMLODIPINE BESYLATE 77 71 32 6
TRAZODONE HCL 76 62 33 22
METOPROLOL TARTRATE 73 63 34 14
VENTOLIN HFA 73 56 34 84
AMITRIPTYLINE HCL 66 15 R 36 42
BUPROPION HCL SR 65 48 37 82
GLYBURIDE 64 42 R 38 75
FLUOXETINE HCL 63 26 39 30
PREDNISONE 63 60 39 40
METHOCARBAMOL 60 43 R 41 173
CRESTOR 59 50 42 34
MELOXICAM 58 46 43 52
HYDROCHLOROTHIAZIDE 56 52 44 9
DILTIAZEM 24HR CD 56 56 44 109
DICYCLOMINE HCL 53 38 46 266
POTASSIUM CHLORIDE 52 52 47 16
FINASTERIDE 51 51 48 104
NOVOLOG 50 49 49 135
FENTANYL 50 48 S2 49 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.